orazepam effect on reducing nausea and vomiting
Phase 2
Completed
- Conditions
- Hyperemesis gravidarum.Hyperemesis gravidarum with metabolic disturbance
- Registration Number
- IRCT2014051917742N2
- Lead Sponsor
- Vice chancellor for research Ahvaz Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Inclusion criteria :Age: 20-60 years, B MI<30, Duration of surgery <1 hour, ASA: I- II
Exclusion criteria: Hemodynamic effect after administration of lorazepam, Anti emetic medication before surgery , Systolic blood pressure less than 90 mmHg or greater than 160 mmHg, History of drug abuse and tricyclic antidepressants
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ausea. Timepoint: 0,6,24 hiurs after surgery. Method of measurement: visual analog scale.;Vomiting. Timepoint: 0,6,24 hiurs after surgery. Method of measurement: visual analog scale.
- Secondary Outcome Measures
Name Time Method Satisfaction. Timepoint: 0,6,24 hours after surgery. Method of measurement: Likert scale.